IRIS Accounts Production v25.2.0.378 06444123 Board of Directors 31.12.24 1.1.24 31.12.24 31.12.24 Medium entities These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. true true true false true true false false false false false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh064441232023-12-31064441232024-12-31064441232024-01-012024-12-31064441232023-03-31064441232023-04-012023-12-31064441232023-12-3106444123ns15:EnglandWales2024-01-012024-12-3106444123ns14:PoundSterling2024-01-012024-12-3106444123ns10:Director12024-01-012024-12-3106444123ns10:Consolidated2024-12-3106444123ns10:ConsolidatedGroupCompanyAccounts2024-01-012024-12-3106444123ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3106444123ns10:Consolidatedns10:MediumEntities2024-01-012024-12-3106444123ns10:Consolidatedns10:Audited2024-01-012024-12-3106444123ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-01-012024-12-3106444123ns10:Medium-sizedCompaniesRegimeForAccounts2024-01-012024-12-3106444123ns10:Consolidated2024-01-012024-12-3106444123ns10:Consolidatedns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-01-012024-12-3106444123ns10:Consolidatedns10:Medium-sizedCompaniesRegimeForAccounts2024-01-012024-12-3106444123ns10:FullAccounts2024-01-012024-12-3106444123ns5:Subsidiary12024-01-012024-12-3106444123ns5:Subsidiary22024-01-012024-12-3106444123ns5:Subsidiary32024-01-012024-12-3106444123ns5:Subsidiary42024-01-012024-12-310644412312024-01-012024-12-3106444123ns10:Director22024-01-012024-12-3106444123ns10:Director32024-01-012024-12-3106444123ns10:Director42024-01-012024-12-3106444123ns10:Director52024-01-012024-12-3106444123ns10:CompanySecretary12024-01-012024-12-3106444123ns10:RegisteredOffice2024-01-012024-12-3106444123ns10:Consolidated2023-04-012023-12-3106444123ns5:CurrentFinancialInstruments2024-12-3106444123ns5:CurrentFinancialInstruments2023-12-3106444123ns5:Non-currentFinancialInstruments2024-12-3106444123ns5:Non-currentFinancialInstruments2023-12-3106444123ns5:ShareCapital2024-12-3106444123ns5:ShareCapital2023-12-3106444123ns5:SharePremium2024-12-3106444123ns5:SharePremium2023-12-3106444123ns5:CapitalRedemptionReserve2024-12-3106444123ns5:CapitalRedemptionReserve2023-12-3106444123ns5:FurtherSpecificReserve1ComponentTotalEquity2024-12-3106444123ns5:FurtherSpecificReserve1ComponentTotalEquity2023-12-3106444123ns5:RetainedEarningsAccumulatedLosses2024-12-3106444123ns5:RetainedEarningsAccumulatedLosses2023-12-3106444123ns5:ShareCapital2023-03-3106444123ns5:RetainedEarningsAccumulatedLosses2023-03-3106444123ns5:SharePremium2023-03-3106444123ns5:RetainedEarningsAccumulatedLosses2023-04-012023-12-3106444123ns5:ShareCapital2024-01-012024-12-3106444123ns5:SharePremium2024-01-012024-12-3106444123ns5:RetainedEarningsAccumulatedLosses2024-01-012024-12-3106444123ns5:CapitalRedemptionReserve2023-03-3106444123ns5:FurtherSpecificReserve1ComponentTotalEquity2023-03-3106444123ns5:CapitalRedemptionReserve2023-04-012023-12-3106444123ns5:FurtherSpecificReserve1ComponentTotalEquity2023-04-012023-12-3106444123ns5:CapitalRedemptionReserve2024-01-012024-12-3106444123ns5:FurtherSpecificReserve1ComponentTotalEquity2024-01-012024-12-3106444123ns5:NetGoodwill2024-01-012024-12-3106444123ns5:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3106444123ns5:ComputerSoftware2024-01-012024-12-3106444123ns5:LongLeaseholdAssetsns5:LandBuildings2024-01-012024-12-3106444123ns5:PlantMachinery2024-01-012024-12-3106444123ns5:FurnitureFittings2024-01-012024-12-3106444123ns5:MotorVehicles2024-01-012024-12-3106444123ns5:ComputerEquipment2024-01-012024-12-3106444123ns5:NetGoodwill2023-12-3106444123ns5:NetGoodwill2024-12-3106444123ns5:NetGoodwill2023-12-3106444123ns5:LongLeaseholdAssetsns5:LandBuildings2023-12-3106444123ns5:PlantMachinery2023-12-3106444123ns5:FurnitureFittings2023-12-3106444123ns5:LongLeaseholdAssetsns5:LandBuildings2024-12-3106444123ns5:PlantMachinery2024-12-3106444123ns5:FurnitureFittings2024-12-3106444123ns5:LongLeaseholdAssetsns5:LandBuildings2023-12-3106444123ns5:PlantMachinery2023-12-3106444123ns5:FurnitureFittings2023-12-3106444123ns5:MotorVehicles2023-12-3106444123ns5:ComputerEquipment2023-12-3106444123ns5:MotorVehicles2024-12-3106444123ns5:ComputerEquipment2024-12-3106444123ns5:MotorVehicles2023-12-3106444123ns5:ComputerEquipment2023-12-3106444123ns5:UnlistedNon-exchangeTradedns5:CostValuation2023-12-3106444123ns5:AdditionsToInvestmentsns5:UnlistedNon-exchangeTraded2024-12-3106444123ns5:UnlistedNon-exchangeTradedns5:CostValuation2024-12-3106444123ns5:UnlistedNon-exchangeTraded2024-12-3106444123ns5:UnlistedNon-exchangeTraded2023-12-31064441231ns5:Subsidiary12024-01-012024-12-3106444123ns5:Subsidiary12024-12-3106444123ns5:Subsidiary12023-12-3106444123ns5:Subsidiary12023-04-012023-12-3106444123ns5:Subsidiary232024-01-012024-12-3106444123ns5:Subsidiary22024-12-3106444123ns5:Subsidiary22023-12-3106444123ns5:Subsidiary22023-04-012023-12-31064441235ns5:Subsidiary32024-01-012024-12-3106444123ns5:Subsidiary32024-12-31064441237ns5:Subsidiary42024-01-012024-12-3106444123ns5:Subsidiary42024-12-3106444123ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3106444123ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3106444123ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-12-3106444123ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2023-12-3106444123ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2024-12-3106444123ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2023-12-3106444123ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2024-12-3106444123ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2023-12-3106444123ns5:HirePurchaseContracts2024-12-3106444123ns5:HirePurchaseContracts2023-12-3106444123ns5:WithinOneYear2024-12-3106444123ns5:WithinOneYear2023-12-3106444123ns5:BetweenOneFiveYears2024-12-3106444123ns5:BetweenOneFiveYears2023-12-3106444123ns5:MoreThanFiveYears2024-12-3106444123ns5:MoreThanFiveYears2023-12-3106444123ns5:AllPeriods2024-12-3106444123ns5:AllPeriods2023-12-3106444123ns5:Secured2024-12-3106444123ns5:Secured2023-12-3106444123ns5:DeferredTaxation2023-12-3106444123ns5:DeferredTaxation2024-01-012024-12-3106444123ns5:DeferredTaxation2024-12-3106444123ns5:RetainedEarningsAccumulatedLosses2023-12-3106444123ns5:SharePremium2023-12-3106444123ns5:CapitalRedemptionReserve2023-12-3106444123ns5:FurtherSpecificReserve1ComponentTotalEquity2023-12-31
REGISTERED NUMBER: 06444123 (England and Wales)







Group Strategic Report, Report of the Directors and

Consolidated Financial Statements for the Year Ended 31st December 2024

for

Plant-Ex Ingredients Ltd

Plant-Ex Ingredients Ltd (Registered number: 06444123)






Contents of the Consolidated Financial Statements
for the Year Ended 31st December 2024




Page

Company Information 1

Group Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 5

Consolidated Income Statement 9

Consolidated Other Comprehensive Income 10

Consolidated Balance Sheet 11

Company Balance Sheet 12

Consolidated Statement of Changes in Equity 13

Company Statement of Changes in Equity 14

Consolidated Cash Flow Statement 15

Notes to the Consolidated Cash Flow Statement 16

Notes to the Consolidated Financial Statements 17


Plant-Ex Ingredients Ltd

Company Information
for the Year Ended 31st December 2024







DIRECTORS: G O R Drewett
S V Barratt
J Donkin
T D R Drewett
J Skade



SECRETARY: A Drewett



REGISTERED OFFICE: Unit 7d Access 18
Avonmouth
Bristol
BS11 8HT



REGISTERED NUMBER: 06444123 (England and Wales)



SENIOR STATUTORY AUDITOR: Matthew Dobbins FCA



AUDITORS: Dunkley's
Statutory Auditor
Chartered Accountants
Woodlands Grange
Woodlands Lane
Bradley Stoke
Bristol
BS32 4JY

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Group Strategic Report
for the Year Ended 31st December 2024

The directors present their strategic report of the company and the group for the year ended 31st December 2024.

REVIEW OF BUSINESS
The Group achieved turnover of £26.3 million in the year ended 31 December 2024, representing a 10% increase compared to the previous year. The Group continues to develop a strong sales pipeline and expects further sales growth during 2025 and beyond.

Operating profit for the year was £1,469k including £851k of one off exceptional costs.

Underlying profit, excluding exceptional costs, was £2,320k and remains in line with the long term plans for the Group.

During the year, the Group commenced a project to increase production capacity in the UK, this project was completed in Q1 2025 and will generate significant additional capacity to support further growth in the UK and export markets.

In April 2025, the Group acquired Aromacolors sp z.o.o., a food ingredients manufacturing business in Poland, with the strategic rationale to increase the Group's manufacturing capability within Europe.

PRINCIPAL RISKS AND UNCERTAINTIES
The directors have considered the major risks and uncertainties facing the Group:

Market Risk

Fluctuating demand in the sector could impact sales. To mitigate this, the Group continues to diversify its customer base, develop innovative new products and expand into new markets.

Supply Chain Disruption

The Group remains exposed to risks associated with global supply chain disruptions and changes to international trade tariffs. Geopolitical tensions and evolving trade agreements continue to impact the cost, availability and lead times of key raw materials. These factors may result in increased operational costs, inventory challenges or delays in delivery timelines. In particular any escalation in tariffs or non-tariff barriers on imports from key trading partners could adversely affect profit margins and pricing competitiveness. To mitigate these risks, the Group maintains a diversified supplier base and regularly reviews sourcing strategies to ensure timely responses to emerging trade constraints.

Regulatory Compliance

Evolving Food Safety and Environmental legislation may impact operational processes. The company closely monitors legal developments and engages with industry bodies to ensure compliance with latest regulations and guidance. During 2025, the Group has invested in additional Technical resource to further mitigate these risks.

Operational Risks

The Group is exposed to labour shortages, driven by a competitive labour market in the UK. This pressure may impact profitability and capacity as the group continues to expand in the UK and overseas. To mitigate these risks, the Group is investing in employee development and engagement initiatives to ensure the Group attracts and retains a motivated and committed workforce.

STRATEGY AND FUTURE OUTLOOK
The Group's strategic focus for the next 3 years includes continued development of new and innovative products to support the Group's customers. Further increases in production capacity both in the UK and other manufacturing facilities across the world. Increased focus on ESG principles across operations; reducing environmental impact, promoting a diverse and inclusive workforce and maintaining high standards of governance.

Despite macroeconomic uncertainty, the board is confident in the company's ability to continue to adapt and grow profitably.

ON BEHALF OF THE BOARD:





G O R Drewett - Director


22nd September 2025

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Report of the Directors
for the Year Ended 31st December 2024

The directors present their report with the financial statements of the company and the group for the year ended 31st December 2024.

PRINCIPAL ACTIVITY
The principal activity of the group in the year under review was that of the manufacture of natural food ingredients.

DIVIDENDS
During the period ended 31 December 2024, £212,140 (2023 - £240,000) of dividends were distributed.

DIRECTORS
G O R Drewett has held office during the whole of the period from 1st January 2024 to the date of this report.

Other changes in directors holding office are as follows:

S V Barratt - appointed 23rd August 2024
J Donkin - appointed 22nd October 2024
T D R Drewett - appointed 22nd October 2024
J Skade - appointed 23rd August 2024

ACQUISITIONS
During the year the following entities were acquired by Plant-ex Ingredients Ltd

Company Location Shareholding

Plant-Ex Ingredients Holding Inc
United States of
America

100%

Plant-Ex Ingredient LLC
United States of
America

100%

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Group Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the group's auditors are aware of that information.

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Report of the Directors
for the Year Ended 31st December 2024


AUDITORS
The auditors, Dunkley's, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





G O R Drewett - Director


22nd September 2025

Report of the Independent Auditors to the Members of
Plant-Ex Ingredients Ltd

Qualified opinion
We have audited the financial statements of Plant-Ex Ingredients Ltd (the 'parent company') and its subsidiaries (the 'group') for the year ended 31st December 2024 which comprise the Consolidated Income Statement, Consolidated Other Comprehensive Income, Consolidated Balance Sheet, Company Balance Sheet, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Cash Flow Statement and Notes to the Consolidated Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion, except for the possible effects of the matter described in the basis for qualified opinion section of our report, the financial statements:

- give a true and fair view of the state of the Group’s affairs as at 31 December 2024 and of the Group’s profit/loss for the year then ended;

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

- have been prepared in accordance with the requirements of the Companies Act 2006

Basis for opinion
It is important to note that this limitation does not extend to the financial year ended 31 December 2024. Based on the procedures performed, we were able to obtain adequate audit evidence for the 2024 financial year, and no similar limitations were encountered in respect of that period.

As a result, our audit opinion is qualified solely with respect to the financial information pertaining to the year ended 31 December 2023.

We were unable to obtain sufficient appropriate audit evidence regarding the existence and completeness of the inventory balance as of 31st December 2023. Specifically, we were unable to observe the physical inventory count at the period-end. Furthermore, we were unable to perform alternative procedures that would provide us with sufficient evidence regarding the completeness and existence of the inventory.

Whilst we were able to verify certain aspects of inventory, such as pricing and the valuation of a sample of items, we were unable to determine whether the total inventory balance accurately reflects all items held as of the balance sheet date and whether all inventory transactions were appropriately recorded. This limitation on the scope of our audit could result in a material misstatement of the inventory balance and related cost of goods sold of £303,913 which would also affect the profit for the period.

We were able to verify the existence and accuracy of the expenditures recorded as of 31st December 2023. However, due to the lack of sufficient documentation and controls, we were unable to vouch for the correct classification of certain expenditures. As a result, we are unable to determine if expenditure totalling £743,127 are correctly classified in the financial statements.

During the 31st December 2023 audit, we were unable to obtain sufficient appropriate audit evidence regarding the completeness of sales transactions. Specifically, we were unable to verify whether the sales transactions for the year were properly recorded due to limitations in the internal controls over the recording and reporting of sales. While we were able to verify a sample of sales transactions and the related revenue recognition, we were unable to determine the completeness of £551,160 of sales.

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the Group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and the provisions available for small entities, in the circumstances set out in note fourteen to the financial statements, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our qualified opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Report of the Independent Auditors to the Members of
Plant-Ex Ingredients Ltd


Other information
The directors are responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Group Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Group Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report of the Directors.


- returns adequate for our audit have not been received from branches not visited by us; or
- the parent company financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so.

Report of the Independent Auditors to the Members of
Plant-Ex Ingredients Ltd


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Extent to which the audit was considered capable of detecting irregularities, including fraud

We identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and then design and perform audit procedures responsive to those risks, including obtaining audit evidence that is sufficient and appropriate to provide a basis for our opinion.

Identifying and assessing potential risks related to irregularities

In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, we considered the following:

- the nature of the industry and sector, control environment and business performance including the design of the company's remuneration policies, bonus levels and performance targets;

- any matters we identified, having obtained and reviewed the company's documentation of their policies and procedures relating to:



o
identifying, evaluating and complying with laws and regulations and whether they were aware of any instances of
non-compliance;



o
detecting and responding to the risks of fraud and whether they have knowledge of any actual, suspected or alleged
fraud;

o the internal controls established to mitigate risks of fraud or non-compliance with laws and regulations;



o
the matters discussed among the audit engagement team regarding how and where fraud might occur in the financial
statements and any potential indicators of fraud.

We also obtained an understanding of the legal and regulatory framework that the company operates in, focusing on provisions of those laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements.

Audit response to risks identified

Our procedures to respond to risks identified included the following:

- enquiring of management, concerning actual and potential litigation and claims;

- performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud;

- in addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments; assessing whether the judgements made in making accounting estimates are indicative of a potential bias; and evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business.

We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members, and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Report of the Independent Auditors to the Members of
Plant-Ex Ingredients Ltd


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Matthew Dobbins FCA (Senior Statutory Auditor)
for and on behalf of Dunkley's
Statutory Auditor
Chartered Accountants
Woodlands Grange
Woodlands Lane
Bradley Stoke
Bristol
BS32 4JY

22nd September 2025

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Consolidated Income Statement
for the Year Ended 31st December 2024

Period
1/4/23
Year Ended to
31/12/24 31/12/23
Notes £    £   

TURNOVER 26,252,109 17,965,187

Cost of sales (16,065,960 ) (11,281,036 )
GROSS PROFIT 10,186,149 6,684,151

Administrative expenses (8,870,903 ) (4,476,828 )
1,315,246 2,207,323

Other operating income 154,179 109,093
OPERATING PROFIT 4 1,469,425 2,316,416

Income from interest in associated undertakings - 54,972
Interest receivable and similar income - 14,442
1,469,425 2,385,830

Interest payable and similar expenses 5 (39,348 ) (12,802 )
PROFIT BEFORE TAXATION 1,430,077 2,373,028

Tax on profit 6 (472,841 ) (499,170 )
PROFIT FOR THE FINANCIAL YEAR 957,236 1,873,858
Profit attributable to:
Owners of the parent 957,236 1,873,858

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Consolidated Other Comprehensive Income
for the Year Ended 31st December 2024

Period
1/4/23
Year Ended to
31/12/24 31/12/23
Notes £    £   

PROFIT FOR THE YEAR 957,236 1,873,858


OTHER COMPREHENSIVE INCOME
Change from associate to subsidiary - (584,844 )
Foreign exchange translation - 11,664
Discounting of fixed term loan 105,571 -
Employee shares granted 551,813 -
Income tax relating to components of other
comprehensive income

-

-
OTHER COMPREHENSIVE INCOME FOR THE YEAR,
NET OF INCOME TAX

657,384

(573,180

)
TOTAL COMPREHENSIVE INCOME FOR THE YEAR 1,614,620 1,300,678

Total comprehensive income attributable to:
Owners of the parent 1,614,620 1,300,678

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Consolidated Balance Sheet
31st December 2024

31.12.24 31.12.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 9 173,780 203,993
Tangible assets 10 2,836,741 1,401,390
Investments 11 - -
3,010,521 1,605,383

CURRENT ASSETS
Stocks 12 5,194,075 4,184,949
Debtors 13 4,575,129 4,677,855
Cash at bank 986,624 652,477
10,755,828 9,515,281
CREDITORS
Amounts falling due within one year 14 4,625,393 6,031,284
NET CURRENT ASSETS 6,130,435 3,483,997
TOTAL ASSETS LESS CURRENT LIABILITIES 9,140,956 5,089,380

CREDITORS
Amounts falling due after more than one year 15 (1,935,204 ) (27,703 )

PROVISIONS FOR LIABILITIES 19 (444,322 ) (127,778 )
NET ASSETS 6,761,430 4,933,899

CAPITAL AND RESERVES
Called up share capital 20 104 100
Share premium 21 436,711 -
Capital redemption reserve 21 105,571 -
Other reserves 21 439,198 -
Retained earnings 21 5,779,846 4,933,799
SHAREHOLDERS' FUNDS 25 6,761,430 4,933,899

The financial statements were approved by the Board of Directors and authorised for issue on 22nd September 2025 and were signed on its behalf by:





G O R Drewett - Director


Plant-Ex Ingredients Ltd (Registered number: 06444123)

Company Balance Sheet
31st December 2024

31.12.24 31.12.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 9 - -
Tangible assets 10 2,762,981 1,368,190
Investments 11 756,296 755,397
3,519,277 2,123,587

CURRENT ASSETS
Stocks 12 4,511,072 3,881,036
Debtors 13 4,708,154 3,941,064
Cash at bank 433,350 431,765
9,652,576 8,253,865
CREDITORS
Amounts falling due within one year 14 4,001,516 4,944,128
NET CURRENT ASSETS 5,651,060 3,309,737
TOTAL ASSETS LESS CURRENT LIABILITIES 9,170,337 5,433,324

CREDITORS
Amounts falling due after more than one year 15 (1,935,204 ) (27,703 )

PROVISIONS FOR LIABILITIES 19 (444,322 ) (127,778 )
NET ASSETS 6,790,811 5,277,843

CAPITAL AND RESERVES
Called up share capital 20 104 100
Share premium 21 436,711 -
Capital redemption reserve 21 105,571 -
Other reserves 21 439,198 -
Retained earnings 21 5,809,227 5,277,743
SHAREHOLDERS' FUNDS 25 6,790,811 5,277,843

Company's profit for the financial year 631,009 1,617,413

The financial statements were approved by the Board of Directors and authorised for issue on 22nd September 2025 and were signed on its behalf by:





G O R Drewett - Director


Plant-Ex Ingredients Ltd (Registered number: 06444123)

Consolidated Statement of Changes in Equity
for the Year Ended 31st December 2024

Called up
share Retained Share
capital earnings premium
£    £    £   
Balance at 1st April 2023 100 3,873,121 -

Changes in equity
Total comprehensive income - 1,300,678 -
Dividends - (240,000 ) -
Balance at 31st December 2023 100 4,933,799 -

Changes in equity
Total comprehensive income - 1,069,851 -
Dividends - (212,140 ) -
Increase in share capital 4 - -
Increase in share premium - - 436,711
Foreign exchange translation - (11,664 ) -
Balance at 31st December 2024 104 5,779,846 436,711
Capital
redemption Other Total
reserve reserves equity
£    £    £   
Balance at 1st April 2023 - - 3,873,221

Changes in equity
Total comprehensive income - - 1,300,678
Dividends - - (240,000 )
Balance at 31st December 2023 - - 4,933,899

Changes in equity
Total comprehensive income 105,571 439,198 1,614,620
Dividends - - (212,140 )
Increase in share capital - - 4
Increase in share premium - - 436,711
Foreign exchange translation - - (11,664 )
Balance at 31st December 2024 105,571 439,198 6,761,430

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Company Statement of Changes in Equity
for the Year Ended 31st December 2024

Called up
share Retained Share
capital earnings premium
£    £    £   
Balance at 1st April 2023 100 3,900,330 -

Changes in equity
Dividends - (240,000 ) -
Total comprehensive income - 1,617,413 -
Balance at 31st December 2023 100 5,277,743 -

Changes in equity
Issue of share capital 4 - 436,711
Dividends - (212,140 ) -
Total comprehensive income - 743,624 -
Balance at 31st December 2024 104 5,809,227 436,711
Capital
redemption Other Total
reserve reserves equity
£    £    £   
Balance at 1st April 2023 - - 3,900,430

Changes in equity
Dividends - - (240,000 )
Total comprehensive income - - 1,617,413
Balance at 31st December 2023 - - 5,277,843

Changes in equity
Issue of share capital - - 436,715
Dividends - - (212,140 )
Total comprehensive income 105,571 439,198 1,288,393
Balance at 31st December 2024 105,571 439,198 6,790,811

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Consolidated Cash Flow Statement
for the Year Ended 31st December 2024

Period
1/4/23
Year Ended to
31/12/24 31/12/23
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 740,466 2,433,653
Interest paid (28,689 ) (236 )
Interest element of hire purchase payments paid (10,659 ) (12,566 )
Finance costs paid - (71,069 )
Tax paid (792,669 ) (264,856 )
Net cash from operating activities (91,551 ) 2,084,926

Cash flows from investing activities
Purchase of intangible fixed assets (12,050 ) (214,193 )
Purchase of tangible fixed assets (1,862,667 ) (272,712 )
Interest received - 14,442
Net cash from investing activities (1,874,717 ) (472,463 )

Cash flows from financing activities
Capital repayments in year (62,588 ) (65,584 )
Amount introduced by directors 1,921,964 -
Amount withdrawn by directors (520 ) 520
Share issue 4 -
Share options 551,813 -
Proceeds from issue of share capital 436,711 -
Present value adjustment on loan 105,570 -
Equity dividends paid (212,140 ) (240,000 )
Net cash from financing activities 2,740,814 (305,064 )

Increase in cash and cash equivalents 774,546 1,307,399
Cash and cash equivalents at beginning of year 2 (12,492 ) (1,319,891 )

Cash and cash equivalents at end of year 2 762,054 (12,492 )

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Notes to the Consolidated Cash Flow Statement
for the Year Ended 31st December 2024

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

Period
1/4/23
Year Ended to
31/12/24 31/12/23
£    £   
Profit before taxation 1,430,077 2,373,028
Depreciation charges 457,916 170,670
Finance costs 39,348 12,802
Finance income - (69,414 )
1,927,341 2,487,086
Increase in stocks (1,009,126 ) (924,275 )
Decrease/(increase) in trade and other debtors 209,551 (848,039 )
(Decrease)/increase in trade and other creditors (387,300 ) 1,718,881
Cash generated from operations 740,466 2,433,653

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31st December 2024
31/12/24 1/1/24
£    £   
Cash and cash equivalents 986,624 652,477
Bank overdrafts (224,570 ) (664,969 )
762,054 (12,492 )
Period ended 31st December 2023
31/12/23 1/4/23
£    £   
Cash and cash equivalents 652,477 194,407
Bank overdrafts (664,969 ) (1,514,298 )
(12,492 ) (1,319,891 )


3. ANALYSIS OF CHANGES IN NET (DEBT)/FUNDS

At 1/1/24 Cash flow At 31/12/24
£    £    £   
Net cash
Cash at bank 652,477 334,147 986,624
Bank overdrafts (664,969 ) 440,399 (224,570 )
(12,492 ) 774,546 762,054
Debt
Finance leases (65,937 ) 53,093 (12,844 )
Debts falling due within 1 year (10,000 ) - (10,000 )
Debts falling due after 1 year (14,859 ) 9,495 (5,364 )
(90,796 ) 62,588 (28,208 )
Total (103,288 ) 837,134 733,846

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Notes to the Consolidated Financial Statements
for the Year Ended 31st December 2024

1. STATUTORY INFORMATION

Plant-Ex Ingredients Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the General Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Associates
Associates are accounted for under the equity method. Under the equity method of accounting, an associate is initially recognised at the transaction price (including transaction costs) and is subsequently adjusted to reflect the investor’s share of the profit or loss, other comprehensive income and equity of the associate.

Related party exemption
The group discloses transactions with related parties in accordance with Section 33 of FRS 102. A related party is defined as a person or entity that is related to the reporting entity, including directors, key management personnel, close family members, and entities under common control.

Transactions with related parties are recorded at arm’s length and in accordance with normal commercial terms.

All related party transactions are reviewed and approved by the board to ensure compliance with applicable accounting standards and governance requirements.

The group has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Transactions between group entities which have been eliminated on consolidation are not disclosed within the financial statements.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2015, is being amortised evenly over its estimated useful life of seven years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Computer software is being amortised evenly over its estimated useful life of nil years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Long leasehold - over remaining period of lease
Plant and machinery - 33.33% on cost and 5% on cost
Fixtures and fittings - 20% on cost
Motor vehicles - 25% on cost
Computer equipment - 33.33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31st December 2024

2. ACCOUNTING POLICIES - continued

Financial instruments
Financial instruments are recognised in the group's balance sheet when the group becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.method.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The group operates a defined contribution pension scheme. Contributions payable to the group's pension scheme are charged to profit or loss in the period to which they relate.

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31st December 2024

2. ACCOUNTING POLICIES - continued

Hyperinflation economies
The Turkish economy was designated as hyperinflation. As a result, application of FRS 102 Section 31 'Hyperinflation' has been applied to subsidiaries whose functional currency is the Turkish lira.

- adjustment of historical cost non-monetary assets and liabilities for the change in purchasing power caused by inflation from the date of initial recognition to the balance sheet date;
- adjustment of the income statement for inflation during the reporting period;
- translation of income statement as at the period-end foreign exchange rate instead of an average rate; and
- adjustment of the income statement to reflect the impact of inflation and exchange rate movement on holding monetary assets and liabilities in local currency.

For foreign subsidiaries, restated financial statements are translated into the Group’s presentation currency using the price index at the reporting date (refer to Note 26).

Share based payments
The Group operates an equity-settled share-based payment scheme under the UK Enterprise Management Incentive (EMI) framework. In accordance with Section 26 of FRS 102 Share-Based Payment, the fair value of equity instruments granted is measured at the grant date and recognised as an expense over the vesting period, with a corresponding increase in equity.

The fair value of EMI options is determined using an appropriate valuation model, taking into account market-based performance conditions where applicable. Non-market vesting conditions are considered in estimating the number of options expected to vest.

The expense is recognised on a straight-line basis over the vesting period, and is adjusted to reflect the actual number of options that vest. No expense is recognised for options that do not vest due to failure to meet non-market conditions.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

3. EMPLOYEES AND DIRECTORS
Period
1/4/23
Year Ended to
31/12/24 31/12/23
£    £   
Wages and salaries 4,297,539 2,161,593
Social security costs 323,216 197,566
Other pension costs 139,334 91,205
4,760,089 2,450,364

The average number of employees during the year was as follows:
Period
1/4/23
Year Ended to
31/12/24 31/12/23

Directors 5 1
Employees 110 99
115 100

Period
1/4/23
Year Ended to
31/12/24 31/12/23
£    £   
Directors' remuneration 136,759 9,902

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31st December 2024

3. EMPLOYEES AND DIRECTORS - continued

Information regarding the highest paid director is as follows:




Year Ended
31.12.24
Period
1.4.23to31.
12.23
£ £
Emoluments etc 58,570 9,902

4. OPERATING PROFIT

The operating profit is stated after charging:

Period
1/4/23
Year Ended to
31/12/24 31/12/23
£    £   
Other operating leases 100,863 55,176
Depreciation - owned assets 427,316 157,304
Goodwill amortisation 30,599 12,450
Auditors' remuneration 37,000 22,000
Auditors' remuneration for non audit work 9,400 9,000
Foreign exchange differences 160,573 10,703

5. INTEREST PAYABLE AND SIMILAR EXPENSES
Period
1/4/23
Year Ended to
31/12/24 31/12/23
£    £   
Bank interest - 289
Other loan interest 28,689 (53 )
Hire purchase 10,659 12,566
39,348 12,802

6. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
Period
1/4/23
Year Ended to
31/12/24 31/12/23
£    £   
Current tax:
UK corporation tax 156,297 530,716

Deferred tax 316,544 (31,546 )
Tax on profit 472,841 499,170

UK corporation tax has been charged at 25 % (2023 - 25 %).

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31st December 2024

6. TAXATION - continued

Tax effects relating to effects of other comprehensive income

31.12.24
Gross Tax Net
£    £    £   
Change from associate to subsidiary
Foreign exchange translation
Discounting of fixed term loan 105,571 - 105,571
Employee shares granted 551,813 - 551,813
657,384 - 657,384

1/4/23 to 31/12/23
Gross Tax Net
£    £    £   
Change from associate to subsidiary (584,844 ) - (584,844 )
Foreign exchange translation 11,664 - 11,664
(573,180 ) - (573,180 )

In the prior period, corporation tax was charged at 25%.

7. INDIVIDUAL INCOME STATEMENT

As permitted by Section 408 of the Companies Act 2006, the Income Statement of the parent company is not presented as part of these financial statements.


8. DIVIDENDS
Period
1/4/23
Year Ended to
31/12/24 31/12/23
£    £   
Ordinary shares of £0.01 each
Interim 212,140 240,000

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31st December 2024

9. INTANGIBLE FIXED ASSETS

Group
Computer
Goodwill software Totals
£    £    £   
COST
At 1st January 2024 284,193 - 284,193
Additions - 386 386
At 31st December 2024 284,193 386 284,579
AMORTISATION
At 1st January 2024 80,200 - 80,200
Amortisation for year 30,599 - 30,599
At 31st December 2024 110,799 - 110,799
NET BOOK VALUE
At 31st December 2024 173,394 386 173,780
At 31st December 2023 203,993 - 203,993

Company
Goodwill
£   
COST
At 1st January 2024
and 31st December 2024 70,000
AMORTISATION
At 1st January 2024
and 31st December 2024 70,000
NET BOOK VALUE
At 31st December 2024 -
At 31st December 2023 -

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31st December 2024

10. TANGIBLE FIXED ASSETS

Group
Fixtures
Long Plant and and
leasehold machinery fittings
£    £    £   
COST
At 1st January 2024 598,386 1,485,687 418,948
Additions 178,662 510,170 1,143,561
Reclassification/transfer - 82,401 8,464
At 31st December 2024 777,048 2,078,258 1,570,973
DEPRECIATION
At 1st January 2024 282,998 633,938 225,930
Charge for year 87,089 174,113 147,637
Reclassification/transfer - 82,401 8,464
At 31st December 2024 370,087 890,452 382,031
NET BOOK VALUE
At 31st December 2024 406,961 1,187,806 1,188,942
At 31st December 2023 315,388 851,749 193,018

Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1st January 2024 47,708 32,882 2,583,611
Additions 17,269 13,005 1,862,667
Reclassification/transfer - - 90,865
At 31st December 2024 64,977 45,887 4,537,143
DEPRECIATION
At 1st January 2024 19,337 20,018 1,182,221
Charge for year 11,619 6,858 427,316
Reclassification/transfer - - 90,865
At 31st December 2024 30,956 26,876 1,700,402
NET BOOK VALUE
At 31st December 2024 34,021 19,011 2,836,741
At 31st December 2023 28,371 12,864 1,401,390

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31st December 2024

10. TANGIBLE FIXED ASSETS - continued

Company
Fixtures
Long Plant and and
leasehold machinery fittings
£    £    £   
COST
At 1st January 2024 598,386 1,454,800 416,635
Additions 178,662 437,982 1,136,051
At 31st December 2024 777,048 1,892,782 1,552,686
DEPRECIATION
At 1st January 2024 282,998 633,938 225,930
Charge for year 87,089 138,632 143,980
At 31st December 2024 370,087 772,570 369,910
NET BOOK VALUE
At 31st December 2024 406,961 1,120,212 1,182,776
At 31st December 2023 315,388 820,862 190,705

Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1st January 2024 47,708 32,882 2,550,411
Additions 17,269 13,005 1,782,969
At 31st December 2024 64,977 45,887 4,333,380
DEPRECIATION
At 1st January 2024 19,337 20,018 1,182,221
Charge for year 11,619 6,858 388,178
At 31st December 2024 30,956 26,876 1,570,399
NET BOOK VALUE
At 31st December 2024 34,021 19,011 2,762,981
At 31st December 2023 28,371 12,864 1,368,190

11. FIXED ASSET INVESTMENTS

Company
Unlisted
investments
£   
COST
At 1st January 2024 755,397
Additions 899
At 31st December 2024 756,296
NET BOOK VALUE
At 31st December 2024 756,296
At 31st December 2023 755,397

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31st December 2024

11. FIXED ASSET INVESTMENTS - continued

The group or the company's investments at the Balance Sheet date in the share capital of companies include the following:

Subsidiaries

Plant-Ex Ingredients (Polska) SP. Z.O.O
Registered office: Ul. Orlat Lwowskich 146 Sosnowiec; Slaskie; 41-208, Poland
Nature of business: Manufacture of Natural food ingredients
%
Class of shares: holding
Ordinary 100.00
31.12.24 31.12.23
£    £   
Aggregate capital and reserves 127,162 70,902
Profit for the year/period 56,260 42,642

Plant-Ex Gida Kimya
Registered office: Hüdai Cd. 10754 Sk. No:No:1/B 42550 Fevzi Çakmak Mh. Karatay, Konya ,Turkey
Nature of business: Manufacture of natural food ingredients
%
Class of shares: holding
Ordinary 100.00
31.12.24 31.12.23
£    £   
Aggregate capital and reserves 506,266 136,558
Profit for the year/period 369,708 169,970

Plant-Ex Ingredients LLC
Registered office: 2001 S. First St., Suite 201, Champaign, IL 61820
Nature of business: Manufacture of natural food ingredients
%
Class of shares: holding
Ordinary 100.00
31.12.24
£   
Aggregate capital and reserves (20,642 )
Loss for the year (20,642 )

Plant-Ex Ingredients Holdings Inc
Registered office: 2001 S. First St., Suite 201, Champaign, IL 61820
Nature of business: Holding company
%
Class of shares: holding
Ordinary 100.00
31.12.24
£   
Aggregate capital and reserves 799


12. STOCKS

Group Company
31.12.24 31.12.23 31.12.24 31.12.23
£    £    £    £   
Stocks 5,194,075 4,184,949 4,511,072 3,881,036

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31st December 2024

13. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
31.12.24 31.12.23 31.12.24 31.12.23
£    £    £    £   
Trade debtors 4,036,261 4,527,546 4,057,960 3,707,811
Amounts owed by group undertakings - - 105,319 85,328
Other debtors 7,022 5,529 7,022 5,021
Tax 106,825 - 106,825 -
VAT 174,977 - 182,862 -
Prepayments 250,044 144,780 248,166 142,904
4,575,129 4,677,855 4,708,154 3,941,064

14. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
31.12.24 31.12.23 31.12.24 31.12.23
£    £    £    £   
Bank loans and overdrafts (see note 16) 234,570 674,969 234,570 674,969
Hire purchase contracts (see note 17) 4,968 53,093 4,968 53,093
Trade creditors 4,007,881 4,299,743 3,396,164 3,248,154
Tax 20,199 549,746 - 517,945
Social security and other taxes 84,907 77,069 83,863 61,337
VAT - 80,715 - 84,102
Other creditors 64,374 31,032 73,457 39,611
Directors' current accounts - 520 - 520
Accruals and deferred income 208,494 264,397 208,494 264,397
4,625,393 6,031,284 4,001,516 4,944,128

15. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

Group Company
31.12.24 31.12.23 31.12.24 31.12.23
£    £    £    £   
Bank loans (see note 16) 5,364 14,859 5,364 14,859
Hire purchase contracts (see note 17) 7,876 12,844 7,876 12,844
Directors' loan accounts 1,921,964 - 1,921,964 -
1,935,204 27,703 1,935,204 27,703

16. LOANS

An analysis of the maturity of loans is given below:

Group Company
31.12.24 31.12.23 31.12.24 31.12.23
£    £    £    £   
Amounts falling due within one year or on demand:
Bank overdrafts 224,570 664,969 224,570 664,969
Bank loans 10,000 10,000 10,000 10,000
234,570 674,969 234,570 674,969
Amounts falling due between one and two years:
Bank loans - 1-2 years 5,364 14,859 5,364 14,859

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31st December 2024

17. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Group
Hire purchase
contracts
31.12.24 31.12.23
£    £   
Net obligations repayable:
Within one year 4,968 53,093
Between one and five years 7,876 12,844
12,844 65,937

Company
Hire purchase
contracts
31.12.24 31.12.23
£    £   
Net obligations repayable:
Within one year 4,968 53,093
Between one and five years 7,876 12,844
12,844 65,937

Group
Non-cancellable
operating leases
31.12.24 31.12.23
£    £   
Within one year 796,107 376,218
Between one and five years 2,595,533 1,226,512
In more than five years 3,556,152 2,544,326
6,947,792 4,147,056

Company
Non-cancellable
operating leases
31.12.24 31.12.23
£    £   
Within one year 756,664 358,667
Between one and five years 2,585,371 1,226,512
In more than five years 3,556,152 2,544,326
6,898,187 4,129,505

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31st December 2024

18. SECURED DEBTS

The following secured debts are included within creditors:

Group Company
31.12.24 31.12.23 31.12.24 31.12.23
£    £    £    £   
Bank loans 15,364 24,859 15,364 24,859
Hire purchase contracts 12,844 65,937 12,844 65,937
Bank borrowing - 51,944 - 51,944
Invoice financing 301,914 629,700 301,914 629,700
330,122 772,440 330,122 772,440

The invoice financing is secured by a fixed and floating charge over the company's assets.

Net obligations under hire purchase contracts are secured by fixed charges on the assets concerned.

19. PROVISIONS FOR LIABILITIES

Group Company
31.12.24 31.12.23 31.12.24 31.12.23
£    £    £    £   
Deferred tax 444,322 127,778 444,322 127,778

Group
Deferred
tax
£   
Balance at 1st January 2024 127,778
Provided during year 316,544
Balance at 31st December 2024 444,322

Company
Deferred
tax
£   
Balance at 1st January 2024 127,778
Charge to Income Statement during year 316,544
Balance at 31st December 2024 444,322

20. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number Class: Nominal value: 31.12.24 31.12.23
7,955 Ordinary £0.01 80 100
2,310 Ordinary A £0.01 23 -
55 Ordinary B £0.0001 1 -

During the year share capital was subdivided from 100 Ordinary shares at £1 to 10,000 ordinary shares at £0.01

During the year 2,241 ordinary shares of £0.01 were redesignated to 2,241 ordinary A shares at £0.01

During the year the following shares were issued:

196 Ordinary shares at £0.01
69 Ordinary A shares at £0.01
55 Ordinary B shares at £0.0001

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31st December 2024

21. RESERVES

Group
Capital
Retained Share redemption Other
earnings premium reserve reserves Totals
£    £    £    £    £   

At 1st January 2024 4,933,799 - - - 4,933,799
Profit for the year 957,236 957,236
Dividends (212,140 ) (212,140 )
Present value adjustment - - 105,571 - 105,571
Share options exercised 112,615 - - (112,615 ) -
Share options introduced - - - 551,813 551,813
Increase in share premium - 436,711 - - 436,711
Foreign exchange translation (11,664 ) - - - (11,664 )
At 31st December 2024 5,779,846 436,711 105,571 439,198 6,761,326

Company
Capital
Retained Share redemption Other
earnings premium reserve reserves Totals
£    £    £    £    £   

At 1st January 2024 5,277,743 - - - 5,277,743
Profit for the year 631,009 631,009
Dividends (212,140 ) (212,140 )
Bonus share issue - 436,711 - - 436,711
Present value adjustment - - 105,571 - 105,571
Share options exercised 112,615 - - (112,615 ) -
Share options introduced - - - 551,813 551,813
At 31st December 2024 5,809,227 436,711 105,571 439,198 6,790,707


22. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the year ended 31st December 2024 and the period ended 31st December 2023:

31.12.24 31.12.23
£    £   
G O R Drewett
Balance outstanding at start of year (520 ) -
Amounts advanced 520 -
Amounts repaid - (520 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - (520 )

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31st December 2024

23. RELATED PARTY DISCLOSURES

During the year an unsecured contractual fixed term loan of £2,000,000 was entered into with the director G O R Drewett and his wife A Drewett equally. The loan has been accounted for at fair value using the interest rates corresponding to the maturity of the contract.

At year end the company owed £1,921,964 in respect to this contract which is repayable by 14 August 2027.

The interest on the loan is 5% per annum.

Nic-Ex Ltd

The company sold £114,419 (2023, £nil) of goods and services to Nic-Ex Ltd a company owned by G O R Drewett who is the director and shareholder of the company, A Drewett who is also a shareholder of this company.

24. ULTIMATE CONTROLLING PARTY

The controlling party is G O R Drewett.

The ultimate controlling party is G O R Drewett.

25. RECONCILIATION OF MOVEMENTS IN SHAREHOLDERS' FUNDS

Group
31.12.24 31.12.23
£    £   
Profit for the financial year 957,236 1,873,858
Dividends (212,140 ) (240,000 )
745,096 1,633,858
Other comprehensive income relating to the year (net) 657,384 (573,180 )
New share capital subscribed 4 -
Share premium 436,711 -
Foreign exchange translation (11,664 ) -
Net addition to shareholders' funds 1,827,531 1,060,678
Opening shareholders' funds 4,933,899 3,873,221
Closing shareholders' funds 6,761,430 4,933,899


Company
31.12.24 31.12.23
£    £   
Profit for the financial year 631,009 1,617,413
Dividends (212,140 ) (240,000 )
418,869 1,377,413
Other comprehensive income relating to the year (net) 657,384 -
New share capital subscribed 4 -
Share premium 436,711 -
Net addition to shareholders' funds 1,512,968 1,377,413
Opening shareholders' funds 5,277,843 3,900,430
Closing shareholders' funds 6,790,811 5,277,843

Plant-Ex Ingredients Ltd (Registered number: 06444123)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31st December 2024

26. HYPERINFLATION

Plant-Ex Ingredients GIDA The financial statements, including comparative figures, have been restated to reflect changes in the general purchasing power of the functional currency, in accordance with Section 31 of FRS 102.

The price index used for restatement was sourced from ExchangeRates.org.uk, and the following exchange rates were applied:

Exchange rates 2024 Exchange rates 2023
Balance sheet 0.023 0.026
Income statement 0.024 0.035

The restatement resulted in a net monetary loss of £28,752, which has been recognised in the income statement for the year.